| Central nervous system involvement by multiple myeloma: a multi‐institutional retrospective study of 172 patients in daily clinical practice A Jurczyszyn, N Grzasko, A Gozzetti, J Czepiel, A Cerase, V Hungria, ... American journal of hematology 91 (6), 575-580, 2016 | 115 | 2016 |
| Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients A Jurczyszyn, J Radocha, J Davila, MA Fiala, A Gozzetti, N Grząśko, ... British Journal of Haematology 180 (6), 831-839, 2018 | 60 | 2018 |
| Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017 A Dmoszyńska, L Usnarska-Zubkiewicz, J Walewski, E Lech-Marańda, ... Acta Haematologica Polonica 48 (2), 55-103, 2017 | 38 | 2017 |
| Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients A Jurczyszyn, M Olszewska-Szopa, V Hungria, E Crusoe, T Pika, ... Leukemia & Lymphoma 57 (9), 2071-2076, 2016 | 33 | 2016 |
| Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2018/2019 K Giannopoulos, K Jamroziak, L Usnarska-Zubkiewicz, D Dytfeld, ... Acta Haematologica Polonica 49 (4), 157-206, 2018 | 25 | 2018 |
| Tumor and cerebrospinal fluid microRNAs in primary central nervous system lymphomas M Zajdel, G Rymkiewicz, M Sromek, M Cieslikowska, P Swoboda, ... Cancers 11 (11), 1647, 2019 | 22 | 2019 |
| Chromosome 1 amplification has similar prognostic value to del (17p13) and t (4; 14)(p16; q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma … N Grzasko, R Hajek, M Hus, S Chocholska, M Morawska, K Giannopoulos, ... Leukemia & lymphoma 58 (9), 2089-2100, 2017 | 17 | 2017 |
| Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma M Kowalska, A Druzd-Sitek, M Fuksiewicz, B Kotowicz, M Chechlinska, ... Clinical biochemistry 43 (6), 604-608, 2010 | 14 | 2010 |
| Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016 A Dmoszyńska, A Walter-Croneck, B Pieńkowska-Grela, ... Acta Haematologica Polonica 47 (2), 39-85, 2016 | 12 | 2016 |
| A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival M Kowalska, J Kaminska, M Fuksiewicz, B Kotowicz, M Chechlinska, ... Medical Oncology 28, 194-198, 2011 | 11 | 2011 |
| Wiejskie organizacje społeczne R Kamiński, A Sitek Ciągłość i zmiana. Sto lat rozwoju polskiej wsi, 421-454, 2019 | 8 | 2019 |
| Recommendations of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma and other plasmacytic dyscrasias for 2018/2019 K Giannopoulos, K Jamroziak, L Usnarska-Zubkiewicz, D Dytfeld, ... Acta Haematol Pol 49 (4), 157-206, 2018 | 8 | 2018 |
| Real-life experience with bortezomib-based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: A Polish retrospective multicenter study I Hus, A Walter-Croneck, A Masternak, A Jurczyszyn, ... Pol Arch Intern Med 127 (11), 765-774, 2017 | 8 | 2017 |
| High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell … I Hus, J Mańko, D Jawniak, A Jurczyszyn, G Charliński, ... Oncology Letters 18 (6), 5811-5820, 2019 | 7 | 2019 |
| Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—a report by Polish Myeloma Study Group A Walter-Croneck, N Grzasko, M Soroka-Wojtaszko, A Jurczyszyn, ... Leukemia Research 38 (7), 788-794, 2014 | 7 | 2014 |
| Efficacy and safety of lenalidomide treatment in multiple myeloma (MM) patients—Report of the Polish Myeloma Group L Usnarska-Zubkiewicz, J Dębski, A Butrym, W Legieć, M Hus, ... Leukemia Research 40, 90-99, 2016 | 6 | 2016 |
| Knowledge Transfer, Knowledge Acquisition and Qualifications in the Context of Rural Development in Poland J Greser, R Kamiński, P Klatta, W Knieć, J Martinez-Perez, A Sitek, ... European Countryside 13 (1), 56-70, 2021 | 5 | 2021 |
| Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with … E Iskierka-Jażdżewska, F Canzian, A Stępień, A Martino, D Campa, ... Leukemia & Lymphoma 61 (3), 699-706, 2020 | 4 | 2020 |
| Preemptive daratumumab therapy for minimal residual disease reappearance or biochemical relapse in multiple myeloma: rationale and design of the polish myeloma consortium … K Jamroziak, K Giannopoulos, T Wrobel, A Nowicki, B Pula, N Grząśko, ... Blood 130, 5404, 2017 | 4 | 2017 |
| e-Zdrowie E Borek, J Greser, A Kilijanek-Cieślik, T Perendyk, A Pruszko, A Sitek, ... Czego oczekują pacjenci, 2017 | 4 | 2017 |
